We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Wearable Biosensors Enable Next-Generation Patient Monitoring

By HospiMedica International staff writers
Posted on 23 Mar 2016
A medical-grade biosensor provides a monitoring solution for at-risk patients in low acuity hospital settings, such as the general ward.

Unlike fitness trackers and consumer focused wearables, the new Royal Philips (Philips; Amsterdam, The Netherlands) connected biosensor automatically and continuously measures heart rate, respiratory rate, skin temperature, single-lead electrocardiogram (ECG), posture, and activity data. More...
The biosensor then transmits the data it collects to a clinical decision support software application, which can be configured to promptly notify the appropriate caregiver or clinician when preset limits are exceeded.

Development of the connected biosensor solution was driven by providers looking for models to address specific issues, such as helping at-risk patients in low acuity hospital areas through recovery and transition to home care, or to help caregivers detect early signs of patient deterioration so that they can intervene early. Philips further plans to introduce a portfolio of integrated solutions which will also connect to analytics tools and dashboards, with the goal of providing clinicians actionable insights that could help improve patient outcomes, reduce costs, and improve access to care.

“We envision a future where patients enabled by connected health technologies will recover faster with fewer complications and greater peace of mind in the hospital and subsequently at home,” said Carla Kriwet, CEO of patient care and monitoring solutions at Philips. “We see the potential for connected sensing solutions and the value created by the rich and actionable data they generate to have a very positive impact on the chronically ill, by helping to reduce associated costly adverse events, complications, unplanned transfers back to the ICU, and longer lengths of hospitalization.”

Philips recently revealed the HealthSuite Digital Platform, a system of wirelessly integrated health measurement devices that gather information for Philips personal health programs. All the devices are Bluetooth enabled, connecting automatically and transferring data to the Philips HealthSuite Health app, so that users can track measurements over time. Among these is the Philips health watch, which continuously and automatically measures a wide range of health biometrics, including heart rate, activity, and sleep patterns.

Related Links:

Royal Philips 



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.